(Q83137403)

English

Can the preoperative Ca-125 level predict optimal cytoreduction in patients with advanced ovarian carcinoma? A single institution cohort study

scientific article published on 01 January 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19119502%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Can the preoperative Ca-125 level predict optimal cytoreduction in patients with advanced ovarian carcinoma? A single institution cohort study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19119502%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

George Vorgias

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19119502%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Christos Iavazzo

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19119502%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Panagiotis Savvopoulos

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19119502%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Eva Myriokefalitaki

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19119502%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Michael Katsoulis

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19119502%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Nickolas Kalinoglou

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19119502%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Thrassivoulos Akrivos

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19119502%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

1 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19119502%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19119502%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

112

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19119502%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19119502%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

11-15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19119502%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.020

7 January 2021

The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.020

7 January 2021

Role of surgery in ovarian cancer: an update

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.020

7 January 2021

Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.020

7 January 2021

Predictive factors for irresectability in advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.020

7 January 2021

Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.020

7 January 2021

Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.020

7 January 2021

The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.020

7 January 2021

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.020

7 January 2021

The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.020

7 January 2021

Preoperative CA-125 level as a predictor of non optimal cytoreduction of advanced epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.020

7 January 2021

Can serum CA-125 levels predict the optimal primary cytoreduction in patients with advanced ovarian carcinoma?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.020

7 January 2021

Preoperative CA 125 levels: an independent prognostic factor for epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.020

7 January 2021

CA125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.020

7 January 2021

Can optimal primary cytoreduction be predicted in advanced stage epithelial ovarian cancer? Role of preoperative serum CA-125 level

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.020

7 January 2021

Preoperative predictors of suboptimal primary surgical cytoreduction in women with clinical evidence of advanced primary epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.020

7 January 2021

Factors associated with cytoreducibility among women with ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.020

7 January 2021

A multicenter study of CA 125 level as a predictor of non-optimal primary cytoreduction of advanced epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.020

7 January 2021

The utility of presurgical CA125 to predict optimal tumor cytoreduction of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.020

7 January 2021

Preoperative serum CA125 levels do not predict suboptimal cytoreductive surgery in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.020

7 January 2021

Survival and prognostic factors in patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.020

7 January 2021

Carcinoma of the Ovary

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.020

7 January 2021

The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.020

7 January 2021

Multivisceral cytoreductive surgery in FIGO stages IIIC and IV epithelial ovarian cancer: results and 5-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.020

7 January 2021

Determination of the necessary total protein substitution requirements in patients with advanced stage ovarian cancer and ascites, undergoing debulking surgery. Correlation with plasma proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.020

7 January 2021

Interval debulking surgery: an alternative for primary surgical debulking?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.020

7 January 2021

Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.020

7 January 2021

Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.09.020

7 January 2021

A study to evaluate the utility of presurgical CA125 to predict optimal tumor cytoreduction of epithelial ovarian cancer

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1016/J.YGYNO.2007.02.027

Identifiers

10.1016/J.YGYNO.2008.09.020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19119502%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19119502%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83137403&oldid=2045331271"